Observational analysis of feeding induced by Δ9-THC and anandamide

被引:153
|
作者
Williams, CM [1 ]
Kirkham, TC [1 ]
机构
[1] Univ Reading, Dept Psychol, Reading RG6 6AL, Berks, England
基金
英国生物技术与生命科学研究理事会;
关键词
endocannabinoids; appetite; eating; prefeed; hyperphagia; incentive; rat;
D O I
10.1016/S0031-9384(02)00725-4
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Endogenous cannabinoid systems have been implicated in the physiological regulation of appetite by the ability of cannabinoid receptor agonists to induce hyperphagia. Both the exogenous cannabinoid Delta(9)-THC and the endocannabinoid arachidonoyl ethanolamide (anandamide) stimulate eating in rats. However, there has been no detailed analysis of the adjustments to feeding behaviour underlying this action. We used observational methods to determine the specific components of feeding affected by these compounds. Two groups (n = 6) of presatiated, male, Lister hooded rats received either Delta(9)-THC (0, 0.5, 1.0 or 2.0 mg/kg) or anandamide (0, 1.0, 5.0 or 10.0 mg/kg sc), and their behaviour in an open field was recorded for 45 min. Behaviour (eating, drinking, rearing, grooming, sniffing, locomotion, resting/inactivity, sleeping) was continuously monitored to provide data on the latency, temporal distribution, duration and frequency of each category. Under control conditions, a minority of animals ate small quantities of lab chow, with feeding beginning only after a long latency. Both Delta(9)-THC and anandamide selectively stimulated feeding, with a marked reduction in latency. Apart from its rapid onset, cannabinoid-induced eating retained the normal, species-typical sequence, characteristic of untreated, free-feeding rats. Our data suggest that exogenously administered cannabinoids promote eating by increasing the incentive value of food and support a role for endocannabinoids in the regulation of the appetitive aspects of feeding motivation. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 50 条
  • [41] First in human trial of an oral tablet with Δ9-THC (Namisol®)
    Klumpers, L. E.
    van Gerven, J. M. A.
    Beumer, T. L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 493 - 493
  • [42] Hair analysis for Δ9-THC, Δ9-THC-COOH, CBN and CBD, by GC/MS-EI.: Comparison with GC/MS-NCI for Δ9-THC-COOH
    Baptista, MJ
    Monsanto, PV
    Marques, EGP
    Bermejo, A
    Avila, S
    Castanheira, AM
    Margalho, C
    Barroso, M
    Vieira, DN
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2002, 128 (1-2) : 66 - 78
  • [43] Variations of Δ9-THC content in single plants of hemp varieties
    Mechtler, K
    Bailer, J
    de Hueber, K
    [J]. INDUSTRIAL CROPS AND PRODUCTS, 2004, 19 (01) : 19 - 24
  • [44] Photodegradation of cannabidiol (CBD) and Δ9-THC in cannabis plant material
    Bini, Arianna
    Salerno, Sofia
    Protti, Stefano
    Pollastro, Federica
    Profumo, Antonella
    Morini, Luca
    Merli, Daniele
    [J]. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2024, 23 (07) : 1239 - 1249
  • [45] An Agathokakological Tale of Δ9-THC: Exploration of Possible Biological Targets
    Mathew, Bijo
    Harilal, Seetha
    Musa, Arafa
    Kumar, Rajesh
    Parambi, Della Grace Thomas
    Jose, Jobin
    Uddin, Md Sahab
    Shah, Muhammad Ajmal
    Behl, Tapan
    Unnikrishnan, Mazhuvancherry Kesavan
    [J]. CURRENT DRUG TARGETS, 2021, 22 (07) : 823 - 834
  • [46] Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans
    Cortes-Briones, Jose
    Skosnik, Patrick D.
    Mathalon, Daniel
    Cahill, John
    Pittman, Brian
    Williams, Ashley
    Sewell, R. Andrew
    Ranganathan, Mohini
    Roach, Brian
    Ford, Judith
    D'Souza, Deepak Cyril
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 (09) : 2124 - 2134
  • [47] Impairment of Synaptic Plasticity by Cannabis, Δ9-THC, and Synthetic Cannabinoids
    Hoffman, Alexander F.
    Hwang, Eun-Kyung
    Lupica, Carl R.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (05):
  • [48] Δ9-THC induced hyperphagia and tolerance assessment:: interactions between the CB1 receptor agonist Δ9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats
    Järbe, TUC
    DiPatrizio, NV
    [J]. BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6): : 373 - 380
  • [49] Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC
    Tagen, Michael
    Klumpers, Linda E.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (15) : 3915 - 3933
  • [50] Apparent pA2 analysis of cannabinoid antagonists in monkeys discriminating Δ9-tetrahydrocannabinol (Δ9-THC)
    McMahon, LR
    [J]. FASEB JOURNAL, 2006, 20 (04): : A682 - A682